Strategic Feasibility Advice is the c4c term to describe the process of providing advice to bring clinical and innovative methodology expertise as well as the patient and parent perspective to paediatric development.
The aim is to expedite the development of high quality paediatric plans/protocols and conduct of feasible paediatric clinical trials and by this the access to well-studied drugs for paediatric patients.

This service provides the industry and academic c4c beneficiaries the opportunity to gain advice on any aspect of paediatric drug development throughout the entire cycle.

The service aims to assist sponsors in new ways to overcome the hurdles of paediatric drug development and to ensure that the study design is patient centred.

Visit website